Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: Re: 7 Big Growth Stories in Biotech: Keith Markey

In case you're wondering where you heard the name Keith Markey,he's the analyst from Griffen Securities.We have their report on MNKD in the link library.(target price $10.25)

http://www.griffinsecurities.com/upload/griffinDoc/Keith%20A.%20Markey%20bio.pdf

Share
New Message
Please login to post a reply